Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22.7M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
14.8M
-
Shares change
-
-952K
-
Total reported value, excl. options
-
$349M
-
Value change
-
-$33.6M
-
Number of buys
-
65
-
Number of sells
-
-76
-
Price
-
$23.64
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q4 2018
165 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q4 2018.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.8M shares
of 22.7M outstanding shares and own 65.09% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.6M shares), Conestoga Capital Advisors, LLC (1.67M shares), Vanguard Group Inc (1.27M shares), DIMENSIONAL FUND ADVISORS LP (1.02M shares), Ranger Investment Management, L.P. (732K shares), JANUS HENDERSON GROUP PLC (672K shares), STATE STREET CORP (595K shares), Epoch Investment Partners, Inc. (394K shares), THOMSON HORSTMANN & BRYANT INC (390K shares), and Summit Creek Advisors LLC (336K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.